Michael Acker
Publications by Year
Research Areas
Mechanical Circulatory Support Devices, Cardiac Structural Anomalies and Repair, Cardiac Valve Diseases and Treatments, Transplantation: Methods and Outcomes, Protein Tyrosine Phosphatases
Most-Cited Works
- → Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases(2016)909 cited
- → The Eukaryotic Translation Initiation Factors eIF1 and eIF1A Induce an Open Conformation of the 40S Ribosome(2007)332 cited
- → Prospective, Multicenter Study of Ventricular Assist Device Infections(2013)256 cited
- → Considerations for the design and reporting of enzyme assays in high-throughput screening applications(2014)216 cited
- → Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer(2020)210 cited
- → Thirteen posttranslational modifications convert a 14-residue peptide into the antibiotic thiocillin(2009)194 cited
- → The HVAD Left Ventricular Assist Device(2015)192 cited
- → Reconstitution of Yeast Translation Initiation(2007)168 cited
- → Inadequate Cardioplegic Protection with Obstructed Coronary Arteries(1979)167 cited
- → Structural reorganization of SHP2 by oncogenic mutations and implications for oncoprotein resistance to allosteric inhibition(2018)163 cited